Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Meibohm

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Pharmaceutics|June 28, 2023
Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide AntibioticsKeyur R Parmar, Pradeep B Lukka, Santosh Wagh, et al.
Molecular Cancer Therapeutics|May 2, 2022
Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast CancerShanshan Deng, Raisa I Krutilina, Kelli L Hartman, et al.
Cell Chemical Biology|May 16, 2025
Pantothenate kinase is an effective target for antifungal therapyJessica Regan, Christian DeJarnette, Parker Reitler, et al.
Thorax|July 5, 2011
Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking?Bram van den Borst, Annemarie Koster, Binbing Yu, et al.
Frontiers in Tuberculosis|February 14, 2025
<i>Mycobacterium abscessus</i> pulmonary infection and associated respiratory function in cystic fibrosis-like βENaC miceCamron M Pearce, Timothy D Shaw, Brendan Podell, et al.
The American Journal of Clinical Nutrition|July 20, 2012
The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung diseaseBram van den Borst, Harry R Gosker, Annemarie Koster, et al.
Journal of Virology|February 12, 2025
The antiviral BDGR-49 provides protection from lethal, neurotropic Venezuelan equine encephalitis virus intranasal infection in miceEvan P Williams, Yi Xue, Peter Vogel, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2008
A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agentsJulian G Hurdle, Robin B Lee, Nageshwar R Budha, et al.
Bioorganic & Medicinal Chemistry|September 22, 2012
Antitubercular nitrofuran isoxazolines with improved pharmacokinetic propertiesRakesh, David Bruhn, Dora B Madhura, et al.
Antiviral Research|June 2, 2025
Broad spectrum antiviral BDGR-164 provides protection against lethal neurotropic alphavirus infection in miceEvan P Williams, Yi Xue, Dong Yang, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Pharmaceutics|June 28, 2023
Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide AntibioticsKeyur R Parmar, Pradeep B Lukka, Santosh Wagh, et al.
Molecular Cancer Therapeutics|May 2, 2022
Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast CancerShanshan Deng, Raisa I Krutilina, Kelli L Hartman, et al.
Cell Chemical Biology|May 16, 2025
Pantothenate kinase is an effective target for antifungal therapyJessica Regan, Christian DeJarnette, Parker Reitler, et al.
Thorax|July 5, 2011
Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking?Bram van den Borst, Annemarie Koster, Binbing Yu, et al.
Frontiers in Tuberculosis|February 14, 2025
<i>Mycobacterium abscessus</i> pulmonary infection and associated respiratory function in cystic fibrosis-like βENaC miceCamron M Pearce, Timothy D Shaw, Brendan Podell, et al.
The American Journal of Clinical Nutrition|July 20, 2012
The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung diseaseBram van den Borst, Harry R Gosker, Annemarie Koster, et al.
Journal of Virology|February 12, 2025
The antiviral BDGR-49 provides protection from lethal, neurotropic Venezuelan equine encephalitis virus intranasal infection in miceEvan P Williams, Yi Xue, Peter Vogel, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2008
A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agentsJulian G Hurdle, Robin B Lee, Nageshwar R Budha, et al.
Bioorganic & Medicinal Chemistry|September 22, 2012
Antitubercular nitrofuran isoxazolines with improved pharmacokinetic propertiesRakesh, David Bruhn, Dora B Madhura, et al.
Antiviral Research|June 2, 2025
Broad spectrum antiviral BDGR-164 provides protection against lethal neurotropic alphavirus infection in miceEvan P Williams, Yi Xue, Dong Yang, et al.
Pageof 18